Screening of hepatitis E in patients presenting for acute neurological disorders
- Belbézier, Aude
- Deroux, Alban
- Sarrot-Reynauld, Françoise
- Colombe, Barbara
- Bosseray, Annick
- Wintenberger, Claire
- Dumanoir, Perrine
- Lugosi, Maxime
- Boccon-Gibod, Isabelle
- Leroy, Vincent
- Maignan, Maxime
- Collomb-Muret, Roselyne
- Viglino, Damien
- Vaillant, Mathieu
- Minotti, Lorella
- Lagrange, Emeline
- Epaulard, Olivier
- Dumestre-Perard, Chantal
- Lhomme, Sébastien
- Lupo, Julien
- Larrat, Sylvie
- Morand, Patrice
- Schwebel, Carole
- Vilotitch, Antoine
- Bosson, Jean-Luc
- Bouillet, Laurence
DOIAbstract
International audienceIntroduction: Hepatitis E virus (HEV) infection has been reported to be associated with neurological disor-ders. However, the real prevalence of acute hepatitis E in those diseases is still unknown. We determinedthe prevalence of anti-HEV IgM antibody in a population with acute non-traumatic, non-metabolic,non-vascular neurological injury.Method: A registry was created in Grenoble Hospital University from 2014 to 2018 to collect data onpatients with acute (<3 months) non-traumatic, non-metabolic, non-vascular neurological injuries. Acutehepatitis E was defined as anti-HEV IgM-positive serum in immunocompetent patient, and as anti-HEVIgM-positive serum or HEV RNA-positive serum in immunocompromised patients.Results: One...
Add to ORKG